Medicine
Iheezo 24 mg/800 mg ophthalmic gel
Iheezo 24 mg/800 mg ophthalmic gel is a prescription medicine containing Chloroprocaine for ophthalmic use, marketed by Harrow Eye, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 15°C to 25°C (59°F to 77°F).
Key facts
- Active ingredient (INN)
- Chloroprocaine
- Brand
- Iheezo
- Strength
- 24 mg/800 mg
- Dosage form
- Ophthalmic gel
- Route
- Ophthalmic
- Packs
- 1 pouch, 5 pouches
- Marketing authorisation holder
- Harrow Eye
- Manufacturer
- Harrow Eye
- Origin register
- US FDA, United States
- Storage
- Store at 15°C to 25°C (59°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N01BA04 Chloroprocaine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 September 2022
- Identifiers
- RxCUI 2613956, 2613961DailyMed set ID ea3b2d2c-8b33-d199-e053-2995a90a699cNDC 82667-300Application NDA216227
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 pouch in 1 carton / 1 vial in 1 pouch / 800 mg in 1 vial | 82667-300-01 | Harrow Eye | 27 September 2022 |
| 5 pouch in 1 carton / 1 vial in 1 pouch / 800 mg in 1 vial | 82667-300-05 | Harrow Eye | 2 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 11 March 1955 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Chloroprocaine
Clinical summary
Chloroprocaine is an ester local anesthetic indicated for the production of local anesthesia by infiltration and peripheral nerve block. It is available as injection and ophthalmic gel for infiltration, perineural and epidural use. MedsAcross supplies Chloroprocaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ChloroprocaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Nesacaine prescribing information (Fresenius Kabi) · U.S. National Library of Medicine, DailyMed
Need Iheezo 24 mg/800 mg ophthalmic gel for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.